Treatment-emergent IMAEs of any grade (in more than 2% of patients) or grade 3 or higher (all events)
| Preferred term . | Total (N = 57) . | |
|---|---|---|
| Any grade . | Grade ≥3 . | |
| Patients with any event, n (%)∗ | 19 (33) | 8 (14) |
| Hypothyroidism | 5 (9) | 0 |
| Pneumonitis | 3 (5) | 1 (2) |
| Rash maculopapular | 3 (5) | 1 (2) |
| Alanine aminotransferase increased | 2 (4) | 1 (2) |
| Aspartate aminotransferase increased | 2 (4) | 1 (2) |
| Dermatitis acneiform | 2 (4) | 0 |
| Rash | 2 (4) | 0 |
| Autoimmune hepatitis | 1 (2) | 1 (2) |
| Colitis | 1 (2) | 1 (2) |
| Dermatitis atopic | 1 (2) | 0 |
| Hypophysitis | 1 (2) | 1 (2) |
| Rash morbilliform | 1 (2) | 1 (2) |
| Transaminases increased | 1 (2) | 1 (2) |
| Preferred term . | Total (N = 57) . | |
|---|---|---|
| Any grade . | Grade ≥3 . | |
| Patients with any event, n (%)∗ | 19 (33) | 8 (14) |
| Hypothyroidism | 5 (9) | 0 |
| Pneumonitis | 3 (5) | 1 (2) |
| Rash maculopapular | 3 (5) | 1 (2) |
| Alanine aminotransferase increased | 2 (4) | 1 (2) |
| Aspartate aminotransferase increased | 2 (4) | 1 (2) |
| Dermatitis acneiform | 2 (4) | 0 |
| Rash | 2 (4) | 0 |
| Autoimmune hepatitis | 1 (2) | 1 (2) |
| Colitis | 1 (2) | 1 (2) |
| Dermatitis atopic | 1 (2) | 0 |
| Hypophysitis | 1 (2) | 1 (2) |
| Rash morbilliform | 1 (2) | 1 (2) |
| Transaminases increased | 1 (2) | 1 (2) |
One patient may have multiple events.